BofA Securities Downgrades Acadia Pharmaceuticals (ACAD) to Neutral

March 10, 2021 6:34 AM EST
Get Alerts ACAD Hot Sheet
Price: $21.66 +0.88%

Rating Summary:
    10 Buy, 13 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 18 | Down: 10 | New: 12
Trade Now! 
Join SI Premium – FREE

BofA Securities analyst Tazeen Ahmad downgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Buy to Neutral.


For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.


Shares of Acadia Pharmaceuticals closed at $25.65 yesterday.


You May Also Be Interested In





Related Categories

Downgrades